Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Interactive 360-degree Videos for Teaching Gut Endoscopy to Undergraduate Medical Students

10 de julio de 2026 actualizado por: Dr Lung-Yi Mak Loey, The University of Hong Kong

Interactive 360-degree Videos for Teaching Gastrointestinal Endoscopy to Undergraduate Medical Students: a Randomized-controlled Cross-over Study

The study is a randomized-controlled cross-over study to evaluate the impact of integrating simulation-based teaching for gastrointestinal endoscopy for medical students. It will establish a novel pedagogy for teaching in a wide array of disciplines in healthcare settings. Building on an innovative virtual teaching platform, investigators will design interactive, immersive 360 virtual reality videos on Video-Vox with a facilitated structured debriefing platform in endoscopy teaching. In medical teaching, clinical exposure is indispensable to students' learning process. However, some premises are not easily accessible, such as operating theatres and endoscopy suites. By using 360 virtual reality technology, participants can be immersed in online screen-based learning in health situations that are difficult to visit in the real world.

The evident advantages of this technology will pave the way to novel approaches to medical education and training. Other real-life clinical settings, such as resuscitation scene in wards, surgical procedures in operation theatres, patient care in intensive care units, can adopt similar teaching platforms for the learner to get a 'first-hand' experience of the situation. The learning process is further reinforced by time-stamps and inquiry-based debriefing. This project will set a springboard for innovative pedagogy for undergraduate teaching in the medical curriculum.

Descripción general del estudio

Estado

Terminado

Descripción detallada

The study would be conducted at the Li Ka Shing Faculty of Medicine, University of Hong Kong (HKU), Hong Kong, China. Second year students were recruited from the HKU's 6-year Bachelor of Medicine and Bachelor of Surgery (MBBS) program, with a cohort size ranging from 250-300 each year at the time this study. The first two years of this program comprise of predominately pre-clinical teaching and is followed by clinical teaching in subsequent years. GI endoscopy teaching for 2nd year students was revised in 2021 to include a lecture and on-site visit to an vacant endoscopy suite without demonstrating actual clinical procedures, to align with the Faculty's initiative for early clinical exposure.

Novice learners will be randomly divided into two groups in a 1:1 ratio. One group received simulation first, followed by conventional teaching (SIM-first); while the other received conventional teaching first, followed by simulation (CON-first). Three domains were assessed to evaluate the effectiveness of the interventions: perceived clinical competency, simulation effectiveness, and student satisfaction. These domains will be assessed after each teaching activity.

Tipo de estudio

Intervencionista

Inscripción (Actual)

68

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Ubicaciones de estudio

      • Hong Kong, Porcelana
        • The University of Hong Kong

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

  • Adulto
  • Adulto Mayor

Acepta Voluntarios Saludables

No

Descripción

Inclusion Criteria:

  • MBBS Year 2 students in the administering institution
  • voluntary participation

Exclusion Criteria:

  • none

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Otro
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación cruzada
  • Enmascaramiento: Único

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Comparador activo: SIM-first
Students who receive simulation first, followed by conventional teaching
A series of 360-degree videos were produced to simulate first-hand experience of the endoscopy room. The videos aimed to replicate authentic situations for clinical decision making. Segments of actual endoscopic procedures conducted in the endoscopic suite at Queen Mary Hospital, Hong Kong, were filmed with a 360-degree camera. Additional footages were filmed with surrogate patients and healthcare professionals to demonstrate the common communication errors and pitfalls that may occur while obtaining consent and conducting the time-out process. For the post-recording editing, views showing endoluminal appearances captured during the procedure were magnified. The vital signs monitor display was highlighted to indicate clinical deterioration. The viewer can pause the video at any time and can manipulate the viewing angle to examine all directions of the endoscopy room. Guiding questions and prompts were integrated within the videos, and were configured to appear at specific time points.
Comparador de placebos: CON-first
Students who receive conventional teaching first, followed by simulation
Participants attended a 60-minute lecture that provided an overview of the different types of GI endoscopy and their indications, as well as common complications and the steps taken to minimize their occurrence.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Self-efficacy by Clinical Competence Questionnaire
Periodo de tiempo: Baseline, Day 2, Day 3
Clinical Competency Questionnaire (CCQ) consists of 5 items of a 10-item 5-point Likert scale (5 = strongly agree, 4 = somewhat agree, 3 = neutral, 2 = somewhat disagree, 1 = strongly disagree). For each question, the minimum score is 0, the maximum score is 5.
Baseline, Day 2, Day 3

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Simulation effectiveness
Periodo de tiempo: Day 2 or Day 3
The Simulation Effectiveness Tool - Modified (SET-M) is a 19-item instrument rated on a 3-point Likert scale (3 = strongly agree, 2 = somewhat agree, 1 = do not agree). For each item, the minimum score is 1, the maximum score is 3. The questionnaire comprises four subscales: pre-briefing, learning, confidence and debriefing.
Day 2 or Day 3
Student satisfaction
Periodo de tiempo: Day 2, Day 3
Participants will be invited to complete a short questionnaire assessing (i) their level of enjoyment and (ii) perceived improvement in knowledge acquisition and recall. These two items were rated using a 5-point Likert scale (5 = strongly agree, 4 = somewhat agree, 3 = neutral, 2 = somewhat disagree, 1 = strongly disagree). For each question, the minimum score is 1, the maximum score is 5. In addition, participants will be invited to give free-text response to identify their favorite aspect of the simulation training as well as areas of improvement.
Day 2, Day 3

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

1 de noviembre de 2024

Finalización primaria (Actual)

30 de diciembre de 2025

Finalización del estudio (Actual)

30 de junio de 2026

Fechas de registro del estudio

Enviado por primera vez

7 de julio de 2026

Primero enviado que cumplió con los criterios de control de calidad

10 de julio de 2026

Publicado por primera vez (Actual)

15 de julio de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

15 de julio de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

10 de julio de 2026

Última verificación

1 de julio de 2026

Más información

Términos relacionados con este estudio

Otros números de identificación del estudio

  • TDG1013

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

SÍ

Descripción del plan IPD

De-identified individual participant data (IPD) collected in this study will be made available to other researchers upon reasonable request to the principal investigator.

Marco de tiempo para compartir IPD

The data will be made available upon reasonable request after publication of study data.

Criterios de acceso compartido de IPD

The data will be made available upon reasonable request to the principal investigator.

Tipo de información de apoyo para compartir IPD

  • PROTOCOLO DE ESTUDIO
  • SAVIA
  • CIF

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir